FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Taro Pharmaceuticals Hydrocortisone 1% and Acetic Acid 2% Otic Recall

Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd

Taro Pharmaceuticals Inc.

Risk level
Class III
Reported by FDA
Nov 15, 2023
Recall ID
D-0089-2024
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals recalled Hydrocortisone 1% and Acetic Acid 2% Otic starting Nov 6, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0089-2024 on Nov 15, 2023. Reason: Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Product description

Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada LGT 1C, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532. NDC 51672-3007-1

Lot numbers, UPCs & expiration codes

Lot# AC86809, AC86812, Exp Date: 01/31/2024

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0089-2024
Classification
Class III
Status
Terminated
Recall initiated
Nov 6, 2023
FDA report date
Nov 15, 2023
Quantity
11,196 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0089-2024, exactly as published.

Show all FDA fields
City
Brampton
Status
Terminated
Country
Canada
Event ID
93337
Address
130 East Dr
Code information
Lot# AC86809, AC86812, Exp Date: 01/31/2024
Report date
Nov 15, 2023
Product type
Drugs
Recall number
D-0089-2024
Classification
Class III
Recalling firm
Taro Pharmaceuticals Inc.
Product quantity
11,196 bottles
Termination date
Aug 27, 2024
Reason for recall
Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada LGT 1C, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532. NDC 51672-3007-1
Distribution pattern
Nationwide in the USA
Recall initiation date
Nov 6, 2023
Initial firm notification
Letter
Center classification date
Nov 6, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0089-2024, published Nov 15, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls